Skip to content

Bristol-Myers Squibb BMY Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$9.57B-12.0%$10.21B-1.3%$15.73B+99.3%$12.6B+100%$10.88B+16.6%
$912M+0.6%$464M-9.6%$776M+280%$1B+179%$907M+167%
$9.37B-13.3%$11.41B+6.2%$11.42B+3.6%$11.42B-0.1%$10.8B+3.4%
$2.76B+3.4%$2.69B+5.2%$2.76B-17.2%$2.74B-11.0%$2.67B-10.7%
$27.21B-11.6%$29.39B-1.3%$35.63B+26.9%$33.22B+23.5%$30.78B+7.4%
$7.66B+6.2%$7.54B+5.7%$7.35B+6.5%$7.37B+7.7%$7.21B+6.9%
$21.74B0.0%$21.75B+0.2%$21.75B0.0%$21.78B+0.2%$21.74B0.0%
$86.48B-6.4%$90.04B-2.8%$96.89B+3.4%$94.68B0.0%$92.43B-6.7%
$4.23B+5.8%$3.58B-0.7%$4.29B+23.6%$5.43B+44.7%$4B+13.1%
$2.31B-35.1%$2.26B+10.5%$4.51B+318%$4.72B+33.5%$3.55B-42.6%
$2.31B-35.1%$2.26B+10.5%$4.51B+318%$4.72B+33.5%$3.55B-42.6%
$19.16B-20.4%$23.42B-1.5%$28.14B+24.3%$27.53B+18.3%$24.07B-6.8%
$42.15B-8.7%$42.85B-10.0%$44.47B-8.6%$44.47B-9.0%$46.16B-6.7%
$66.37B-11.5%$71.53B-6.1%$78.29B+2.4%$77.19B-0.5%$74.98B-9.1%
$292M0.0%$292M0.0%$292M0.0%$292M0.0%$292M0.0%
$18.29B+13.5%$16.9B+13.3%$17.09B+6.2%$16.15B+0.3%$16.11B+3.0%
$20.07B+15.4%$18.47B+13.1%$18.55B+8.2%$17.44B+2.5%$17.39B+5.5%
$86.48B-6.4%$90.04B-2.8%$96.89B+3.4%$94.68B0.0%$92.43B-6.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bristol-Myers Squibb's total assets?
Bristol-Myers Squibb (BMY) holds $86.5B in total assets, down 6.4% year over year.
How much debt does Bristol-Myers Squibb have?
Bristol-Myers Squibb carries $44.7B in total debt against $20.1B of shareholders' equity, a debt-to-equity ratio of 2.23.
How much cash does Bristol-Myers Squibb have?
Bristol-Myers Squibb holds $9.6B in cash and equivalents.
Can Bristol-Myers Squibb cover its short-term obligations?
Its current ratio is 1.42 — current assets exceed current liabilities.
Where does Bristol-Myers Squibb's balance sheet data come from?
Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.